Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Read more
Subcategories of "Inhibitors"
Angiogenesis
Apoptosis
Cell Cycle/Checkpoint
Chromatin/Epigenetics
Cytoskeletal Signaling
DNA Damage/DNA Repair
Endocrinology/Hormones
Enzyme
GPCR/G-Protein
Immunology and Inflammation
Influenza Virus
JAK/STAT signaling
MAPK Signaling
Membrane Transporter/Ion Channel
Metabolism
Microbiology/Virology
Neuroscience
Other Inhibitors
Oxidation-Reduction
PI3K/Akt/mTOR Signaling
Proteases/Proteasome
Stem Cell and Derivatives
Tyrosine Kinase/Adaptors
Ubiquitination
Show 16 more subcategories
Products of "Inhibitors"
Resolvin E4
CAS:1781227-87-9
RvE4, a bioactive lipid from eicosapentaenoic acid and synthesized by 15-LO, is anti-inflammatory and boosts …
Formula:
C20H30O4
Color and Shape:
Solid
Molecular weight:
334.45
Ref: TM-T38043
| 10µg | 280.00 € | ||
| 25µg | 646.00 € | ||
| 50µg | 1,210.00 € | ||
| 100µg | 2,127.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
FLT3/TrKA-IN-1
FLT3/TrKA-IN-1: Potent dual kinase inhibitor for FLT3 & TrKA, promising for AML research.
Formula:
C28H30N4O2
Color and Shape:
Solid
Molecular weight:
454.56
Ref: TM-T62801
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
FCE-24379
CAS:113869-44-6
FCE-24379 is a selective antagonist of vascular serotonin receptors that has been shown to lowers …
Formula:
C20H22N4O2
Color and Shape:
Solid
Molecular weight:
350.41
Ref: TM-T71396
| 25mg | 6,258.00 € | ||
| 50mg | 8,300.00 € | ||
| 100mg | 12,005.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
Lumirubin
CAS:83664-21-5
Lumirubin is a water-soluble photoproduct of bilirubin formed in vivo during phototherapy.
Formula:
C33H36N4O6
Color and Shape:
Solid
Molecular weight:
584.66
Ref: TM-T32951
| 25mg | 6,116.00 € | ||
| 50mg | 8,111.00 € | ||
| 100mg | 11,722.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
Axl-IN-3
Axl-IN-3 is a selective, potent and orally active inhibitor of AXL kinase (IC50: 41.5 nM) …
Formula:
C24H25ClN6O2
Color and Shape:
Solid
Molecular weight:
464.95
Ref: TM-T62962
| 25mg | 1,437.00 € | ||
| 50mg | 1,872.00 € | ||
| 100mg | 2,364.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
Evixapodlin
CAS:2374856-75-2
Evixapodlin (PD-1/PD-L1-IN 7) is a human PD-1/PD-L1 protein/protein interaction inhibitor (IC50: 0.213).Evixapodlin has anticancer and …
Formula:
C34H36Cl2N8O4
Purity:
99.07%
Color and Shape:
Solid
Molecular weight:
691.61
Ref: TM-T36487
| 1mg | 109.00 € | ||
| 5mg | 260.00 € | ||
| 10mg | 415.00 € | ||
| 25mg | 787.00 € | ||
| 50mg | 1,049.00 € | ||
| 100mg | 1,421.00 € | ||
| 1mL*10mM (DMSO) | 403.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
Tuvatidine
CAS:91257-14-6
Tuvatidine is a histamine 2 receptor antagonist.
Formula:
C10H17N9O2S3
Color and Shape:
Solid
Molecular weight:
391.5
Ref: TM-T68381
| 25mg | 2,070.00 € | ||
| 50mg | 2,717.00 € | ||
| 100mg | 3,647.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
RXR antagonist 2
RXR antagonist 2 is a potent antagonist of RXR (Ki: 0.391 μM, Kd: 0.281 μM). …
Formula:
C29H35F3N2O3
Color and Shape:
Solid
Molecular weight:
516.6
Ref: TM-T63597
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
IRAK4-IN-18
IRAK4-IN-18: Potent IRAK4 inhibitor (IC50: 15 nM), reduces IL23 in cells, prevents rat arthritis.
Formula:
C24H25FN6O3
Color and Shape:
Solid
Molecular weight:
464.49
Ref: TM-T62950
| 25mg | 1,437.00 € | ||
| 50mg | 1,872.00 € | ||
| 100mg | 2,364.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
HDAC/HSP90-IN-4
HDAC/HSP90-IN-4 inhibits HDAC (20 IC50=194nM, 26 IC50=360nM) & HSP90α (20 IC50=153nM, 26 IC50=77nM), affects cancer …
Formula:
C20H23N3O6
Color and Shape:
Solid
Molecular weight:
401.15869
Ref: TM-T64261
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
GENZ-882706
CAS:2070864-35-4
GENZ-882706 is a potent colony stimulating factor-1 receptor (CSF-1R) Inhibitor.
Formula:
C26H25N5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
455.51
Ref: TM-T11390
| 25mg | 1,976.00 € | ||
| 50mg | 2,588.00 € | ||
| 100mg | 4,152.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
RDN2150
CAS:2839429-51-3
RDN2150 (Compound 25), a ZAP-70 inhibitor with an IC50 of 14.6 nM, covalently binds to …
Formula:
C28H29ClN8O4
Color and Shape:
Solid
Molecular weight:
577.03
Ref: TM-T81308
| 1mg | 274.00 € | ||
| 5mg | 610.00 € | ||
| 10mg | 933.00 € | ||
| 25mg | 1,872.00 € | ||
| 50mg | 3,091.00 € | ||
| 100mg | 4,179.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
CEP-14083
CAS:856692-39-2
CEP-14083: potent ALK inhibitor, effective in NPM/ALK T-cell lymphoma, binds ATP site; IC50=11 nmol/L, also …
Formula:
C31H30N6O2
Color and Shape:
Solid
Molecular weight:
518.61
Ref: TM-T68538
| 25mg | 2,288.00 € | ||
| 50mg | 3,006.00 € | ||
| 100mg | 4,065.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
HSP90-IN-11
HSP90-IN-11: potent HSP90 inhibitor, akin to AUY-922; hinders CRC/NSCLC cell proliferation; degrades EGFR, Akt proteins.
Formula:
C27H30FN3O6
Color and Shape:
Solid
Molecular weight:
511.54
Ref: TM-T63528
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
PARP-1/HDAC-IN-1
CAS:3032621-10-3
PARP-1/HDAC-IN-1 is a PARP-1 and HDAC6 inhibitor with anticancer, antimigratory, and antiangiogenic activities and is …
Formula:
C22H18N4O4
Purity:
95.94%
Color and Shape:
Solid
Molecular weight:
402.4
Ref: TM-T61962
| 1mg | 274.00 € | ||
| 5mg | 674.00 € | ||
| 10mg | 922.00 € | ||
| 25mg | 1,437.00 € | ||
| 50mg | 1,872.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
Urease-IN-2
Urease-IN-2 is a non-competitive inhibitor of urease (IC50: 0.94 μM, Ki: 1.6 μM) that non-competitively …
Formula:
C26H25N5O5S3
Color and Shape:
Solid
Molecular weight:
583.7
Ref: TM-T64121
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
XPO1-IN-1
XPO1-IN-1: an oral MM.1S cell inhibitor (IC50: 24 nM), induces apoptosis, stable metabolism, good pharmacokinetics.
Formula:
C20H15F6N5O3S
Color and Shape:
Solid
Molecular weight:
519.42
Ref: TM-T63623
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
PPARα/γ agonist 1
PPARα/γ agonist 1 is a potent and dual PPARα/γ partial agonist which is a promising …
Formula:
C18H19NO2
Color and Shape:
Solid
Molecular weight:
281.35
Ref: TM-T60535
| 25mg | 1,437.00 € | ||
| 50mg | 1,872.00 € | ||
| 100mg | 2,364.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
Tubulin inhibitor 19
Tubulin inhibitor 19 (9b), a potent indole chalcone, strongly blocks tubulin, valuable in cancer studies.
Formula:
C21H23NO5
Color and Shape:
Solid
Molecular weight:
369.41
Ref: TM-T61459
| 25mg | 1,386.00 € | ||
| 50mg | 1,805.00 € | ||
| 100mg | 2,279.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
Cap-dependent endonuclease-IN-1
CAS:2365473-17-0
Cap-dependent endonuclease-IN-1: potent, oral inhibitor with antiviral properties against influenza.
Formula:
C27H22F2N2O6S
Purity:
98.88% - 99.09%
Color and Shape:
Liquid
Molecular weight:
540.54
Ref: TM-T63808
| 1mg | 602.00 € | ||
| 5mg | 1,288.00 € | ||
| 25mg | 2,111.00 € | ||
| 50mg | 2,631.00 € | ||
| 100mg | 3,266.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
